Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PRPH - ProPhase Labs Inc


IEX Last Trade
2.71
0.310   11.439%

Share volume: 25,485
Last Updated: Fri 30 Aug 2024 08:28:07 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$2.40
0.31
12.92%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
8%
Profitability 0%
Dept financing 4%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
-15.41%
3 Months
-45.55%
6 Months
-43.25%
1 Year
-39.00%
2 Year
-77.38%
Key data
Stock price
$2.71
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.04 - $7.48
52 WEEK CHANGE
-$0.38
MARKET CAP 
51.321 M
YIELD 
N/A
SHARES OUTSTANDING 
19.079 M
DIVIDEND
$0.30
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.37
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$26,682
AVERAGE 30 VOLUME 
$32,359
Company detail
CEO:
Region: US
Website: prophaselabs.com
Employees: 53
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

prophase labs is a diversified natural health medical science company. for more information visit us at www.prophaselabs.com.

Recent news